BRCA1 inhibition of estrogen receptor signaling in transfected cells

被引：396

作者：

Fan, S

Wang, JA

Yuan, R

Ma, Y

Meng, Q

Erdos, MR

Pestell, RG

Yuan, F

Auborn, KJ

Goldberg, ID

Rosen, EM

机构：

[1] Albert Einstein Coll Med, Long Isl Jewish Med Ctr, Dept Radiat Oncol, New Hyde Park, NY 11040 USA

[2] Albert Einstein Coll Med, Long Isl Jewish Med Ctr, Dept Otolaryngol, New Hyde Park, NY 11040 USA

[3] N Shore Univ Hosp, NSUH LIJ Hlth Syst, Dept Radiat Oncol, Manhasset, NY 11030 USA

[4] NIH, Genet & Mol Biol Branch, Natl Human Genome Res Inst, Bethesda, MD 20892 USA

[5] Yeshiva Univ Albert Einstein Coll Med, Dept Dev, Bronx, NY 10461 USA

[6] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Biol, Bronx, NY 10461 USA

[7] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA

来源：

SCIENCE | 1999年 / 284卷 / 5418期

关键词：

D O I：

10.1126/science.284.5418.1354

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Mutations of the breast cancer susceptibility gene BRCA1 confer increased risk for breast, ovarian, and prostatic cancers, but it is not clear why the mutations are associated with these particular tumor types. In transient transfection assays, BRCA1 was found to inhibit signaling by the Ligand-activated estrogen receptor (ER-alpha) through the estrogen-responsive enhancer element and to block the transcriptional activation function AF-2 of ER-alpha. These results raise the possibility that wild-type BRCA1 suppresses estrogen-dependent transcriptional pathways related to mammary epithelial cell proliferation and that Loss of this ability contributes to tumorigenesis.

引用

页码：1354 / 1356

页数：3

共 22 条

[1] V-SRC AND EJ RAS ALLEVIATE REPRESSION OF C-JUN BY A CELL-SPECIFIC INHIBITOR
BAICHWAL, VR
PARK, A
TJIAN, R
[J]. NATURE, 1991, 352 (6331) : 165 - 168
[2] Transcriptional activation by BRCA1
Chapman, MS
Verma, IM
[J]. NATURE, 1996, 382 (6593) : 678 - 679
[3] Chen YM, 1996, CANCER RES, V56, P3168
[4] BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins
Fan, SJ
Wang, JA
Yuan, RQ
Ma, YX
Meng, QH
Erdos, MR
Brody, LC
Goldberg, ID
Rosen, EM
[J]. ONCOGENE, 1998, 16 (23) : 3069 - 3082
[5] Regulation of estrogen receptor α function in breast cancer
Ferguson, AT
Davidson, NE
[J]. CRITICAL REVIEWS IN ONCOGENESIS, 1997, 8 (01): : 29 - 46
[6] E2F-1-MEDIATED TRANSACTIVATION IS INHIBITED BY COMPLEX-FORMATION WITH THE RETINOBLASTOMA SUSCEPTIBILITY GENE-PRODUCT
FLEMINGTON, EK
SPECK, SH
KAELIN, WG
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) : 6914 - 6918
[7] RISKS OF CANCER IN BRCA1-MUTATION CARRIERS
FORD, D
EASTON, DF
BISHOP, DT
NAROD, SA
GOLDGAR, DE
HAITES, N
MILNER, B
ALLAN, L
PONDER, BAJ
PETO, J
SMITH, S
STRATTON, M
LENOIR, GM
FEUNTEUN, J
LYNCH, H
ARASON, A
BARKARDOTTIR, R
EGILSSON, V
BLACK, DM
KELSELL, D
SPURR, N
DEVILEE, P
CORNELISSE, CJ
VARSEN, H
BIRCH, JM
SKOLNICK, M
SANTIBANEZKOREF, MS
TEARE, D
STEEL, M
PORTER, D
COHEN, BB
CAROTHERS, A
SMYTH, E
WEBER, B
NEWBOLD, B
BOEHNKE, M
COLLINS, FS
CANNONALBRIGHT, LA
GOLDGAR, D
[J]. LANCET, 1994, 343 (8899) : 692 - 695
[8] RETRACTED: BRCA1 required for transcription-coupled repair of oxidative DNA damage (Retracted article. See vol 300, pg 1657, June 13 2003)
Gowen, LC
Avrutskaya, AV
Latour, AM
Koller, BH
Leadon, SA
[J]. SCIENCE, 1998, 281 (5379) : 1009 - 1012
[9] The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse
Hakem, R
delaPompa, JL
Sirard, C
Mo, R
Woo, M
Hakem, A
Wakeham, A
Potter, J
Reitmair, A
Billia, F
Firpo, E
Hui, CC
Roberts, J
Rossant, J
Mak, TW
[J]. CELL, 1996, 85 (07) : 1009 - 1023
[10] AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors
Henttu, PMA
Kalkhoven, E
Parker, MG
[J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) : 1832 - 1839

← 1 2 3 →